Skip to main content

Peer Review reports

From: Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice

Original Submission
13 Jan 2018 Submitted Original manuscript
26 Apr 2018 Author responded Author comments - Alberto Borghetti
23 Jan 2018 Reviewed Reviewer Report - Franco Maggiolo
15 Mar 2018 Reviewed Reviewer Report - Vincent Soriano
Resubmission - Version 2
26 Apr 2018 Submitted Manuscript version 2
30 Nov 2018 Author responded Author comments - Alberto Borghetti
6 May 2018 Reviewed Reviewer Report - Franco Maggiolo
4 Jun 2018 Reviewed Reviewer Report - Massimiliano Lanzafame
Resubmission - Version 3
30 Nov 2018 Submitted Manuscript version 3
14 Dec 2018 Author responded Author comments - Alberto Borghetti
Resubmission - Version 4
14 Dec 2018 Submitted Manuscript version 4
18 Dec 2018 Author responded Author comments - Alberto Borghetti
Resubmission - Version 5
18 Dec 2018 Submitted Manuscript version 5
22 Dec 2018 Author responded Author comments - Alberto Borghetti
Resubmission - Version 6
22 Dec 2018 Submitted Manuscript version 6
Publishing
28 Dec 2018 Editorially accepted
17 Jan 2019 Article published 10.1186/s12879-018-3666-8

You can find further information about peer review here.

Back to article page